Cargando…
An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus
Influenza A viruses (IAV) have been a major public health threat worldwide, and options for antiviral therapy become increasingly limited with the emergence of drug-resisting virus strains. New and effective anti-IAV drugs, especially for highly pathogenic influenza, with different modes of action,...
Autores principales: | Ye, Mengdie, Liao, Yixian, Wu, Li, Qi, Wenbao, Choudhry, Namrta, Liu, Yahong, Chen, Weisan, Song, Gaopeng, Chen, Jianxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077228/ https://www.ncbi.nlm.nih.gov/pubmed/32085430 http://dx.doi.org/10.3390/v12020225 |
Ejemplares similares
-
Saikosaponin A inhibits influenza A virus replication and lung immunopathology
por: Chen, Jianxin, et al.
Publicado: (2015) -
Inhibition of Influenza H7 Hemagglutinin-Mediated Entry
por: Antanasijevic, Aleksandar, et al.
Publicado: (2013) -
Antiviral Effect of Ginsenosides rk1 against Influenza a Virus Infection by Targeting the Hemagglutinin 1-Mediated Virus Attachment
por: Yang, Xia, et al.
Publicado: (2023) -
Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin
por: Yang, Jie, et al.
Publicado: (2013) -
Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry
por: Du, Ruikun, et al.
Publicado: (2019)